No new brain infection cases with MS drug Tysabri
Reuters - USA
Tysabri, developed with Irish drugmaker Elan Corp. (ELN.I: Quote, Profile, Research), was taken off the market in 2005 after being linked with three cases ...
See all stories on this topic

Opexa to Present T-Cell Technology at Conference
Woodlands Online, LLC - The Woodlands,TX,USA
... of its proprietary T-cell and stem cell therapies. The Company's lead product, Tovaxin, a T-cell therapy for multiple sclerosis is in Phase IIb trials. ...
See all stories on this topic

Stem-cell political science
Pittsburgh Tribune-Review - Pittsburgh,PA,USA
... research surpass those from embryonic stem-cell research. According to the experts, the former has shown promise in combatting multiple sclerosis, ...
See all stories on this topic

Going the Distance
ADVANCE for Physician Assistants - King of Prussia,PA,USA
Sativex, a cannabinoid medication used to treat chronic neuropathic pain in multiple sclerosis patients, was recently introduced in Canada.13 Its ...
See all stories on this topic

Peggy Townsend, Name Dropping: MS treatment expensive proposition ...
Santa Cruz Sentinel - Santa Cruz,CA,USA
The diagnosis that came was multiple sclerosis, and it derailed his plans to finish college and become a water resource manager. ...
See all stories on this topic

Possible New MRI Marker for Multiple Sclerosis Progression
MedPage Today - Little Falls,NJ,USA
... relapsing-remitting multiple sclerosis (63%). The remaining 34% had secondary-progressive disease. Those with primary-progressive disease were excluded. ...
See all stories on this topic

Multiple Sclerosis Disease Progression Clarified Through MRI
Science Daily Tue, 28 Aug 2007 6:03 AM PDT
Using magnetic resonance images of the brain, researchers have identified a new abnormality related to disease progression and disability in patients with multiple sclerosis, according to a new study. There are four classifications of MS, but the two most common types are relapsing-remitting and secondary-progressive. Patients with relapsing-remitting MS will experience symptom flare-ups followed ...

New MRI finding sheds light on multiple sclerosis disease progressio
EurekAlert! Mon, 27 Aug 2007 9:07 PM PDT
OAK BROOK, Ill. – Using magnetic resonance (MR) images of the brain, researchers have identified a new abnormality related to disease progression and disability in patients with multiple sclerosis (MS), according to a study published in the August issue of Radiology.

New MRI Finding Sheds Light on Multiple Sclerosis Disease Progression
PRWeb Tue, 28 Aug 2007 0:22 AM PDT
Study results appear in the September issue of Radiology. (PRWeb Aug 28, 2007) Post Comment:Trackback URL: http://www.prweb.com/pingpr.php/SGFsZi1Qcm9mLUZhbHUtSGFsZi1UaGlyLVplcm8=

New MRI Finding Sheds Light on Multiple Sclerosis Disease Progression
PRWeb via Yahoo! News Tue, 28 Aug 2007 0:00 AM PDT
Study results appear in the September issue of Radiology.

Novel MS Drug Shows Promise In Two Lethal Leukemias
Science Daily (press release) - USA
The laboratory and animal study focused on the drug, called fingolimod. Researchers said it might help patients with advanced chronic myelogenous leukemia ...
See all stories on this topic